nodes	percent_of_prediction	percent_of_DWPC	metapath
Rosuvastatin—ABCC1—Vemurafenib—skin cancer	0.0979	0.116	CbGbCtD
Rosuvastatin—ABCG2—Vismodegib—skin cancer	0.0829	0.098	CbGbCtD
Rosuvastatin—ABCG2—Vemurafenib—skin cancer	0.0655	0.0774	CbGbCtD
Rosuvastatin—ABCC1—Dactinomycin—skin cancer	0.0651	0.0769	CbGbCtD
Rosuvastatin—ALB—Vismodegib—skin cancer	0.0571	0.0675	CbGbCtD
Rosuvastatin—ABCC4—Fluorouracil—skin cancer	0.0547	0.0647	CbGbCtD
Rosuvastatin—SLCO1B3—Docetaxel—skin cancer	0.0486	0.0574	CbGbCtD
Rosuvastatin—ALB—Vemurafenib—skin cancer	0.0452	0.0534	CbGbCtD
Rosuvastatin—ABCG2—Dactinomycin—skin cancer	0.0435	0.0515	CbGbCtD
Rosuvastatin—CYP2C19—Vismodegib—skin cancer	0.037	0.0438	CbGbCtD
Rosuvastatin—ABCC1—Docetaxel—skin cancer	0.0336	0.0397	CbGbCtD
Rosuvastatin—CYP2C9—Vismodegib—skin cancer	0.0308	0.0364	CbGbCtD
Rosuvastatin—ABCG2—Fluorouracil—skin cancer	0.0294	0.0348	CbGbCtD
Rosuvastatin—CYP3A4—Imiquimod—skin cancer	0.0258	0.0305	CbGbCtD
Rosuvastatin—CYP3A4—Temozolomide—skin cancer	0.0258	0.0305	CbGbCtD
Rosuvastatin—ABCG2—Docetaxel—skin cancer	0.0225	0.0266	CbGbCtD
Rosuvastatin—ALB—Fluorouracil—skin cancer	0.0203	0.024	CbGbCtD
Rosuvastatin—CYP3A4—Vismodegib—skin cancer	0.0179	0.0212	CbGbCtD
Rosuvastatin—CYP3A4—Vemurafenib—skin cancer	0.0142	0.0167	CbGbCtD
Rosuvastatin—SLC7A11—forelimb zeugopod—skin cancer	0.0135	0.403	CbGeAlD
Rosuvastatin—CYP3A5—Docetaxel—skin cancer	0.0125	0.0147	CbGbCtD
Rosuvastatin—CYP2C9—Fluorouracil—skin cancer	0.0109	0.0129	CbGbCtD
Rosuvastatin—Musculoskeletal disorder—Vismodegib—skin cancer	0.00833	0.0719	CcSEcCtD
Rosuvastatin—CYP3A4—Docetaxel—skin cancer	0.00486	0.00574	CbGbCtD
Rosuvastatin—HMGCR—Sorafenib—Vismodegib—skin cancer	0.00465	1	CbGdCrCtD
Rosuvastatin—Hepatic enzyme increased—Vismodegib—skin cancer	0.00314	0.0272	CcSEcCtD
Rosuvastatin—Memory loss—Fluorouracil—skin cancer	0.00294	0.0254	CcSEcCtD
Rosuvastatin—Breast disorder—Vismodegib—skin cancer	0.00195	0.0168	CcSEcCtD
Rosuvastatin—HMGCR—hair follicle—skin cancer	0.00193	0.0577	CbGeAlD
Rosuvastatin—Proteinuria—Imiquimod—skin cancer	0.00178	0.0154	CcSEcCtD
Rosuvastatin—Protein urine present—Imiquimod—skin cancer	0.00176	0.0152	CcSEcCtD
Rosuvastatin—Hepatic enzyme increased—Imiquimod—skin cancer	0.00166	0.0143	CcSEcCtD
Rosuvastatin—Myopathy—Temozolomide—skin cancer	0.00134	0.0116	CcSEcCtD
Rosuvastatin—HMGCR—nipple—skin cancer	0.00131	0.0391	CbGeAlD
Rosuvastatin—HMGCR—neck—skin cancer	0.00129	0.0387	CbGeAlD
Rosuvastatin—Injury—Imiquimod—skin cancer	0.00124	0.0107	CcSEcCtD
Rosuvastatin—ABCC1—hair follicle—skin cancer	0.00123	0.0369	CbGeAlD
Rosuvastatin—Memory impairment—Temozolomide—skin cancer	0.0012	0.0103	CcSEcCtD
Rosuvastatin—Myalgia—Vismodegib—skin cancer	0.00111	0.00956	CcSEcCtD
Rosuvastatin—Arthralgia—Vismodegib—skin cancer	0.00111	0.00956	CcSEcCtD
Rosuvastatin—SLC7A11—female reproductive system—skin cancer	0.00105	0.0315	CbGeAlD
Rosuvastatin—Nervous system disorder—Vismodegib—skin cancer	0.00104	0.00899	CcSEcCtD
Rosuvastatin—Breast disorder—Imiquimod—skin cancer	0.00103	0.00888	CcSEcCtD
Rosuvastatin—Neuropathy peripheral—Vemurafenib—skin cancer	0.00101	0.0087	CcSEcCtD
Rosuvastatin—Hepatic enzyme increased—Temozolomide—skin cancer	0.000993	0.00857	CcSEcCtD
Rosuvastatin—Influenza—Imiquimod—skin cancer	0.000983	0.00849	CcSEcCtD
Rosuvastatin—Musculoskeletal discomfort—Vismodegib—skin cancer	0.000967	0.00835	CcSEcCtD
Rosuvastatin—Bronchitis—Imiquimod—skin cancer	0.000946	0.00817	CcSEcCtD
Rosuvastatin—Dyspepsia—Vismodegib—skin cancer	0.000934	0.00807	CcSEcCtD
Rosuvastatin—HMGCR—connective tissue—skin cancer	0.000928	0.0277	CbGeAlD
Rosuvastatin—Constipation—Vismodegib—skin cancer	0.000908	0.00784	CcSEcCtD
Rosuvastatin—Pain—Vismodegib—skin cancer	0.000908	0.00784	CcSEcCtD
Rosuvastatin—HMGCR—epithelium—skin cancer	0.000881	0.0263	CbGeAlD
Rosuvastatin—Injury—Bleomycin—skin cancer	0.000879	0.00759	CcSEcCtD
Rosuvastatin—SLC7A11—head—skin cancer	0.000879	0.0263	CbGeAlD
Rosuvastatin—Depression—Imiquimod—skin cancer	0.000874	0.00755	CcSEcCtD
Rosuvastatin—Gastrointestinal pain—Vismodegib—skin cancer	0.000868	0.00749	CcSEcCtD
Rosuvastatin—Neuropathy peripheral—Imiquimod—skin cancer	0.000859	0.00742	CcSEcCtD
Rosuvastatin—Urinary tract infection—Imiquimod—skin cancer	0.000852	0.00736	CcSEcCtD
Rosuvastatin—Abdominal pain—Vismodegib—skin cancer	0.000839	0.00724	CcSEcCtD
Rosuvastatin—Hepatic failure—Dactinomycin—skin cancer	0.000839	0.00724	CcSEcCtD
Rosuvastatin—HMGCR—skin of body—skin cancer	0.000838	0.025	CbGeAlD
Rosuvastatin—ABCC1—nipple—skin cancer	0.000837	0.025	CbGeAlD
Rosuvastatin—Hepatobiliary disease—Imiquimod—skin cancer	0.000829	0.00716	CcSEcCtD
Rosuvastatin—Sinusitis—Imiquimod—skin cancer	0.000823	0.0071	CcSEcCtD
Rosuvastatin—Rhinitis—Imiquimod—skin cancer	0.000789	0.00681	CcSEcCtD
Rosuvastatin—Pharyngitis—Imiquimod—skin cancer	0.000781	0.00675	CcSEcCtD
Rosuvastatin—Gastroenteritis—Temozolomide—skin cancer	0.000769	0.00664	CcSEcCtD
Rosuvastatin—HMGCR—mammalian vulva—skin cancer	0.000764	0.0228	CbGeAlD
Rosuvastatin—Asthenia—Vismodegib—skin cancer	0.000761	0.00658	CcSEcCtD
Rosuvastatin—Hepatic failure—Temozolomide—skin cancer	0.000759	0.00655	CcSEcCtD
Rosuvastatin—Pruritus—Vismodegib—skin cancer	0.000751	0.00648	CcSEcCtD
Rosuvastatin—Diarrhoea—Vismodegib—skin cancer	0.000726	0.00627	CcSEcCtD
Rosuvastatin—Amnesia—Temozolomide—skin cancer	0.000726	0.00627	CcSEcCtD
Rosuvastatin—Arrhythmia—Imiquimod—skin cancer	0.000703	0.00607	CcSEcCtD
Rosuvastatin—Cough—Vemurafenib—skin cancer	0.000701	0.00605	CcSEcCtD
Rosuvastatin—Mental disorder—Imiquimod—skin cancer	0.00069	0.00595	CcSEcCtD
Rosuvastatin—Myalgia—Vemurafenib—skin cancer	0.000684	0.00591	CcSEcCtD
Rosuvastatin—Arthralgia—Vemurafenib—skin cancer	0.000684	0.00591	CcSEcCtD
Rosuvastatin—HMGCR—lymphoid tissue—skin cancer	0.000678	0.0203	CbGeAlD
Rosuvastatin—Drug interaction—Docetaxel—skin cancer	0.000673	0.00581	CcSEcCtD
Rosuvastatin—Rash—Vismodegib—skin cancer	0.000669	0.00578	CcSEcCtD
Rosuvastatin—Amnesia—Fluorouracil—skin cancer	0.000669	0.00577	CcSEcCtD
Rosuvastatin—Dermatitis—Vismodegib—skin cancer	0.000669	0.00577	CcSEcCtD
Rosuvastatin—HMGCR—female reproductive system—skin cancer	0.000654	0.0196	CbGeAlD
Rosuvastatin—Infection—Vemurafenib—skin cancer	0.000651	0.00562	CcSEcCtD
Rosuvastatin—Nervous system disorder—Vemurafenib—skin cancer	0.000643	0.00555	CcSEcCtD
Rosuvastatin—Nausea—Vismodegib—skin cancer	0.00063	0.00544	CcSEcCtD
Rosuvastatin—SLCO1B1—female reproductive system—skin cancer	0.000627	0.0187	CbGeAlD
Rosuvastatin—Angioedema—Imiquimod—skin cancer	0.000626	0.00541	CcSEcCtD
Rosuvastatin—Breast disorder—Temozolomide—skin cancer	0.000616	0.00532	CcSEcCtD
Rosuvastatin—Muscular weakness—Temozolomide—skin cancer	0.000601	0.00519	CcSEcCtD
Rosuvastatin—Cough—Imiquimod—skin cancer	0.000598	0.00516	CcSEcCtD
Rosuvastatin—Musculoskeletal discomfort—Vemurafenib—skin cancer	0.000597	0.00516	CcSEcCtD
Rosuvastatin—Haematuria—Bleomycin—skin cancer	0.000594	0.00513	CcSEcCtD
Rosuvastatin—Myalgia—Imiquimod—skin cancer	0.000583	0.00504	CcSEcCtD
Rosuvastatin—Arthralgia—Imiquimod—skin cancer	0.000583	0.00504	CcSEcCtD
Rosuvastatin—Bronchitis—Temozolomide—skin cancer	0.000567	0.00489	CcSEcCtD
Rosuvastatin—Constipation—Vemurafenib—skin cancer	0.000561	0.00484	CcSEcCtD
Rosuvastatin—Infection—Imiquimod—skin cancer	0.000556	0.0048	CcSEcCtD
Rosuvastatin—SLCO2B1—female reproductive system—skin cancer	0.000554	0.0166	CbGeAlD
Rosuvastatin—Muscular weakness—Fluorouracil—skin cancer	0.000554	0.00478	CcSEcCtD
Rosuvastatin—Nervous system disorder—Imiquimod—skin cancer	0.000548	0.00474	CcSEcCtD
Rosuvastatin—HMGCR—head—skin cancer	0.000547	0.0163	CbGeAlD
Rosuvastatin—Depression—Temozolomide—skin cancer	0.000524	0.00452	CcSEcCtD
Rosuvastatin—Hepatitis—Dactinomycin—skin cancer	0.000521	0.0045	CcSEcCtD
Rosuvastatin—Pharyngitis—Dactinomycin—skin cancer	0.000518	0.00447	CcSEcCtD
Rosuvastatin—Neuropathy peripheral—Temozolomide—skin cancer	0.000515	0.00445	CcSEcCtD
Rosuvastatin—Urinary tract infection—Temozolomide—skin cancer	0.000511	0.00441	CcSEcCtD
Rosuvastatin—Musculoskeletal discomfort—Imiquimod—skin cancer	0.000509	0.0044	CcSEcCtD
Rosuvastatin—Insomnia—Imiquimod—skin cancer	0.000506	0.00437	CcSEcCtD
Rosuvastatin—Hepatic failure—Docetaxel—skin cancer	0.000505	0.00436	CcSEcCtD
Rosuvastatin—Paraesthesia—Imiquimod—skin cancer	0.000502	0.00434	CcSEcCtD
Rosuvastatin—Hepatobiliary disease—Temozolomide—skin cancer	0.000497	0.00429	CcSEcCtD
Rosuvastatin—Sinusitis—Temozolomide—skin cancer	0.000493	0.00426	CcSEcCtD
Rosuvastatin—Dyspepsia—Imiquimod—skin cancer	0.000492	0.00425	CcSEcCtD
Rosuvastatin—ABCC4—female reproductive system—skin cancer	0.000491	0.0147	CbGeAlD
Rosuvastatin—ABCC1—mammalian vulva—skin cancer	0.000489	0.0146	CbGeAlD
Rosuvastatin—Hypersensitivity—Vemurafenib—skin cancer	0.000483	0.00417	CcSEcCtD
Rosuvastatin—Pain—Imiquimod—skin cancer	0.000478	0.00413	CcSEcCtD
Rosuvastatin—Neuropathy peripheral—Fluorouracil—skin cancer	0.000475	0.0041	CcSEcCtD
Rosuvastatin—Hepatitis—Temozolomide—skin cancer	0.000472	0.00407	CcSEcCtD
Rosuvastatin—Urinary tract infection—Fluorouracil—skin cancer	0.000471	0.00406	CcSEcCtD
Rosuvastatin—Asthenia—Vemurafenib—skin cancer	0.00047	0.00406	CcSEcCtD
Rosuvastatin—Pharyngitis—Temozolomide—skin cancer	0.000468	0.00404	CcSEcCtD
Rosuvastatin—Pruritus—Vemurafenib—skin cancer	0.000464	0.00401	CcSEcCtD
Rosuvastatin—SLCO2B1—head—skin cancer	0.000463	0.0138	CbGeAlD
Rosuvastatin—Feeling abnormal—Imiquimod—skin cancer	0.000461	0.00398	CcSEcCtD
Rosuvastatin—Gastrointestinal pain—Imiquimod—skin cancer	0.000457	0.00395	CcSEcCtD
Rosuvastatin—Sinusitis—Fluorouracil—skin cancer	0.000454	0.00392	CcSEcCtD
Rosuvastatin—Diarrhoea—Vemurafenib—skin cancer	0.000449	0.00387	CcSEcCtD
Rosuvastatin—Urticaria—Imiquimod—skin cancer	0.000444	0.00384	CcSEcCtD
Rosuvastatin—Abdominal pain—Imiquimod—skin cancer	0.000442	0.00382	CcSEcCtD
Rosuvastatin—Rhinitis—Fluorouracil—skin cancer	0.000436	0.00376	CcSEcCtD
Rosuvastatin—Dizziness—Vemurafenib—skin cancer	0.000434	0.00374	CcSEcCtD
Rosuvastatin—Pharyngitis—Fluorouracil—skin cancer	0.000431	0.00372	CcSEcCtD
Rosuvastatin—SLCO1A2—head—skin cancer	0.000426	0.0127	CbGeAlD
Rosuvastatin—Cough—Bleomycin—skin cancer	0.000425	0.00367	CcSEcCtD
Rosuvastatin—Myalgia—Bleomycin—skin cancer	0.000414	0.00358	CcSEcCtD
Rosuvastatin—Rash—Vemurafenib—skin cancer	0.000413	0.00357	CcSEcCtD
Rosuvastatin—Mental disorder—Temozolomide—skin cancer	0.000413	0.00357	CcSEcCtD
Rosuvastatin—Dermatitis—Vemurafenib—skin cancer	0.000413	0.00357	CcSEcCtD
Rosuvastatin—Hypersensitivity—Imiquimod—skin cancer	0.000412	0.00356	CcSEcCtD
Rosuvastatin—Headache—Vemurafenib—skin cancer	0.000411	0.00355	CcSEcCtD
Rosuvastatin—ABCC4—head—skin cancer	0.00041	0.0123	CbGeAlD
Rosuvastatin—Breast disorder—Docetaxel—skin cancer	0.00041	0.00354	CcSEcCtD
Rosuvastatin—ABCG2—mammalian vulva—skin cancer	0.000405	0.0121	CbGeAlD
Rosuvastatin—Asthenia—Imiquimod—skin cancer	0.000401	0.00346	CcSEcCtD
Rosuvastatin—Confusional state—Bleomycin—skin cancer	0.000401	0.00346	CcSEcCtD
Rosuvastatin—Pruritus—Imiquimod—skin cancer	0.000396	0.00342	CcSEcCtD
Rosuvastatin—Infection—Bleomycin—skin cancer	0.000395	0.00341	CcSEcCtD
Rosuvastatin—Nausea—Vemurafenib—skin cancer	0.000389	0.00336	CcSEcCtD
Rosuvastatin—Thrombocytopenia—Bleomycin—skin cancer	0.000389	0.00336	CcSEcCtD
Rosuvastatin—Arrhythmia—Fluorouracil—skin cancer	0.000388	0.00335	CcSEcCtD
Rosuvastatin—Myalgia—Dactinomycin—skin cancer	0.000386	0.00334	CcSEcCtD
Rosuvastatin—HMGCR—lymph node—skin cancer	0.000383	0.0114	CbGeAlD
Rosuvastatin—Diarrhoea—Imiquimod—skin cancer	0.000383	0.0033	CcSEcCtD
Rosuvastatin—Angioedema—Temozolomide—skin cancer	0.000375	0.00324	CcSEcCtD
Rosuvastatin—Dizziness—Imiquimod—skin cancer	0.00037	0.00319	CcSEcCtD
Rosuvastatin—Infection—Dactinomycin—skin cancer	0.000368	0.00318	CcSEcCtD
Rosuvastatin—Thrombocytopenia—Dactinomycin—skin cancer	0.000363	0.00313	CcSEcCtD
Rosuvastatin—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000362	0.00313	CcSEcCtD
Rosuvastatin—Cough—Temozolomide—skin cancer	0.000358	0.00309	CcSEcCtD
Rosuvastatin—Paraesthesia—Bleomycin—skin cancer	0.000357	0.00308	CcSEcCtD
Rosuvastatin—Rash—Imiquimod—skin cancer	0.000353	0.00304	CcSEcCtD
Rosuvastatin—Dermatitis—Imiquimod—skin cancer	0.000352	0.00304	CcSEcCtD
Rosuvastatin—Headache—Imiquimod—skin cancer	0.00035	0.00302	CcSEcCtD
Rosuvastatin—Myalgia—Temozolomide—skin cancer	0.00035	0.00302	CcSEcCtD
Rosuvastatin—Arthralgia—Temozolomide—skin cancer	0.00035	0.00302	CcSEcCtD
Rosuvastatin—Neuropathy peripheral—Docetaxel—skin cancer	0.000342	0.00296	CcSEcCtD
Rosuvastatin—Jaundice—Docetaxel—skin cancer	0.000341	0.00294	CcSEcCtD
Rosuvastatin—Pain—Bleomycin—skin cancer	0.00034	0.00293	CcSEcCtD
Rosuvastatin—Confusional state—Temozolomide—skin cancer	0.000338	0.00292	CcSEcCtD
Rosuvastatin—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000338	0.00291	CcSEcCtD
Rosuvastatin—Infection—Temozolomide—skin cancer	0.000333	0.00287	CcSEcCtD
Rosuvastatin—Nausea—Imiquimod—skin cancer	0.000332	0.00287	CcSEcCtD
Rosuvastatin—Hepatobiliary disease—Docetaxel—skin cancer	0.00033	0.00285	CcSEcCtD
Rosuvastatin—Nervous system disorder—Temozolomide—skin cancer	0.000329	0.00284	CcSEcCtD
Rosuvastatin—Thrombocytopenia—Temozolomide—skin cancer	0.000328	0.00283	CcSEcCtD
Rosuvastatin—Feeling abnormal—Bleomycin—skin cancer	0.000327	0.00283	CcSEcCtD
Rosuvastatin—SLCO2B1—lymph node—skin cancer	0.000324	0.00969	CbGeAlD
Rosuvastatin—Myalgia—Fluorouracil—skin cancer	0.000322	0.00278	CcSEcCtD
Rosuvastatin—Pain—Dactinomycin—skin cancer	0.000317	0.00274	CcSEcCtD
Rosuvastatin—CYP2C9—female reproductive system—skin cancer	0.000317	0.00946	CbGeAlD
Rosuvastatin—Urticaria—Bleomycin—skin cancer	0.000316	0.00273	CcSEcCtD
Rosuvastatin—Rhinitis—Docetaxel—skin cancer	0.000314	0.00272	CcSEcCtD
Rosuvastatin—Hepatitis—Docetaxel—skin cancer	0.000314	0.00271	CcSEcCtD
Rosuvastatin—Confusional state—Fluorouracil—skin cancer	0.000311	0.00269	CcSEcCtD
Rosuvastatin—Pharyngitis—Docetaxel—skin cancer	0.000311	0.00269	CcSEcCtD
Rosuvastatin—Infection—Fluorouracil—skin cancer	0.000307	0.00265	CcSEcCtD
Rosuvastatin—Feeling abnormal—Dactinomycin—skin cancer	0.000305	0.00264	CcSEcCtD
Rosuvastatin—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000305	0.00264	CcSEcCtD
Rosuvastatin—Insomnia—Temozolomide—skin cancer	0.000303	0.00262	CcSEcCtD
Rosuvastatin—Gastrointestinal pain—Dactinomycin—skin cancer	0.000303	0.00262	CcSEcCtD
Rosuvastatin—Nervous system disorder—Fluorouracil—skin cancer	0.000303	0.00261	CcSEcCtD
Rosuvastatin—Thrombocytopenia—Fluorouracil—skin cancer	0.000302	0.00261	CcSEcCtD
Rosuvastatin—Paraesthesia—Temozolomide—skin cancer	0.000301	0.0026	CcSEcCtD
Rosuvastatin—ALB—lymph node—skin cancer	0.000297	0.00887	CbGeAlD
Rosuvastatin—Dyspepsia—Temozolomide—skin cancer	0.000295	0.00255	CcSEcCtD
Rosuvastatin—Abdominal pain—Dactinomycin—skin cancer	0.000293	0.00253	CcSEcCtD
Rosuvastatin—Hypersensitivity—Bleomycin—skin cancer	0.000293	0.00253	CcSEcCtD
Rosuvastatin—ABCC4—lymph node—skin cancer	0.000287	0.00858	CbGeAlD
Rosuvastatin—Constipation—Temozolomide—skin cancer	0.000287	0.00247	CcSEcCtD
Rosuvastatin—Pain—Temozolomide—skin cancer	0.000287	0.00247	CcSEcCtD
Rosuvastatin—Asthenia—Bleomycin—skin cancer	0.000285	0.00246	CcSEcCtD
Rosuvastatin—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000281	0.00243	CcSEcCtD
Rosuvastatin—Pruritus—Bleomycin—skin cancer	0.000281	0.00243	CcSEcCtD
Rosuvastatin—Arrhythmia—Docetaxel—skin cancer	0.00028	0.00242	CcSEcCtD
Rosuvastatin—Insomnia—Fluorouracil—skin cancer	0.000279	0.00241	CcSEcCtD
Rosuvastatin—Paraesthesia—Fluorouracil—skin cancer	0.000277	0.00239	CcSEcCtD
Rosuvastatin—Feeling abnormal—Temozolomide—skin cancer	0.000276	0.00238	CcSEcCtD
Rosuvastatin—Mental disorder—Docetaxel—skin cancer	0.000275	0.00237	CcSEcCtD
Rosuvastatin—Gastrointestinal pain—Temozolomide—skin cancer	0.000274	0.00237	CcSEcCtD
Rosuvastatin—Hypersensitivity—Dactinomycin—skin cancer	0.000273	0.00236	CcSEcCtD
Rosuvastatin—Dyspepsia—Fluorouracil—skin cancer	0.000272	0.00235	CcSEcCtD
Rosuvastatin—Urticaria—Temozolomide—skin cancer	0.000266	0.0023	CcSEcCtD
Rosuvastatin—Asthenia—Dactinomycin—skin cancer	0.000266	0.0023	CcSEcCtD
Rosuvastatin—Abdominal pain—Temozolomide—skin cancer	0.000265	0.00229	CcSEcCtD
Rosuvastatin—Pain—Fluorouracil—skin cancer	0.000264	0.00228	CcSEcCtD
Rosuvastatin—Feeling abnormal—Fluorouracil—skin cancer	0.000254	0.0022	CcSEcCtD
Rosuvastatin—Diarrhoea—Dactinomycin—skin cancer	0.000253	0.00219	CcSEcCtD
Rosuvastatin—Rash—Bleomycin—skin cancer	0.00025	0.00216	CcSEcCtD
Rosuvastatin—Dermatitis—Bleomycin—skin cancer	0.00025	0.00216	CcSEcCtD
Rosuvastatin—Hypersensitivity—Temozolomide—skin cancer	0.000247	0.00213	CcSEcCtD
Rosuvastatin—Urticaria—Fluorouracil—skin cancer	0.000245	0.00212	CcSEcCtD
Rosuvastatin—ABCC1—lymph node—skin cancer	0.000245	0.00732	CbGeAlD
Rosuvastatin—CYP3A4—female reproductive system—skin cancer	0.000241	0.00722	CbGeAlD
Rosuvastatin—Asthenia—Temozolomide—skin cancer	0.00024	0.00208	CcSEcCtD
Rosuvastatin—Cough—Docetaxel—skin cancer	0.000238	0.00206	CcSEcCtD
Rosuvastatin—Pruritus—Temozolomide—skin cancer	0.000237	0.00205	CcSEcCtD
Rosuvastatin—Nausea—Bleomycin—skin cancer	0.000236	0.00204	CcSEcCtD
Rosuvastatin—Rash—Dactinomycin—skin cancer	0.000234	0.00202	CcSEcCtD
Rosuvastatin—Arthralgia—Docetaxel—skin cancer	0.000232	0.00201	CcSEcCtD
Rosuvastatin—Myalgia—Docetaxel—skin cancer	0.000232	0.00201	CcSEcCtD
Rosuvastatin—Diarrhoea—Temozolomide—skin cancer	0.000229	0.00198	CcSEcCtD
Rosuvastatin—Hypersensitivity—Fluorouracil—skin cancer	0.000227	0.00196	CcSEcCtD
Rosuvastatin—Confusional state—Docetaxel—skin cancer	0.000225	0.00194	CcSEcCtD
Rosuvastatin—Dizziness—Temozolomide—skin cancer	0.000222	0.00191	CcSEcCtD
Rosuvastatin—Infection—Docetaxel—skin cancer	0.000221	0.00191	CcSEcCtD
Rosuvastatin—Nausea—Dactinomycin—skin cancer	0.00022	0.0019	CcSEcCtD
Rosuvastatin—Nervous system disorder—Docetaxel—skin cancer	0.000219	0.00189	CcSEcCtD
Rosuvastatin—Pruritus—Fluorouracil—skin cancer	0.000218	0.00189	CcSEcCtD
Rosuvastatin—Thrombocytopenia—Docetaxel—skin cancer	0.000218	0.00188	CcSEcCtD
Rosuvastatin—Rash—Temozolomide—skin cancer	0.000211	0.00182	CcSEcCtD
Rosuvastatin—Diarrhoea—Fluorouracil—skin cancer	0.000211	0.00182	CcSEcCtD
Rosuvastatin—Dermatitis—Temozolomide—skin cancer	0.000211	0.00182	CcSEcCtD
Rosuvastatin—Headache—Temozolomide—skin cancer	0.00021	0.00181	CcSEcCtD
Rosuvastatin—Dizziness—Fluorouracil—skin cancer	0.000204	0.00176	CcSEcCtD
Rosuvastatin—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000203	0.00175	CcSEcCtD
Rosuvastatin—ABCG2—lymph node—skin cancer	0.000203	0.00606	CbGeAlD
Rosuvastatin—Insomnia—Docetaxel—skin cancer	0.000202	0.00174	CcSEcCtD
Rosuvastatin—Paraesthesia—Docetaxel—skin cancer	0.0002	0.00173	CcSEcCtD
Rosuvastatin—Nausea—Temozolomide—skin cancer	0.000199	0.00172	CcSEcCtD
Rosuvastatin—Dyspepsia—Docetaxel—skin cancer	0.000196	0.00169	CcSEcCtD
Rosuvastatin—Rash—Fluorouracil—skin cancer	0.000195	0.00168	CcSEcCtD
Rosuvastatin—Dermatitis—Fluorouracil—skin cancer	0.000194	0.00168	CcSEcCtD
Rosuvastatin—Headache—Fluorouracil—skin cancer	0.000193	0.00167	CcSEcCtD
Rosuvastatin—Constipation—Docetaxel—skin cancer	0.000191	0.00165	CcSEcCtD
Rosuvastatin—Pain—Docetaxel—skin cancer	0.000191	0.00165	CcSEcCtD
Rosuvastatin—Feeling abnormal—Docetaxel—skin cancer	0.000184	0.00159	CcSEcCtD
Rosuvastatin—Nausea—Fluorouracil—skin cancer	0.000183	0.00158	CcSEcCtD
Rosuvastatin—Gastrointestinal pain—Docetaxel—skin cancer	0.000182	0.00157	CcSEcCtD
Rosuvastatin—Abdominal pain—Docetaxel—skin cancer	0.000176	0.00152	CcSEcCtD
Rosuvastatin—Hypersensitivity—Docetaxel—skin cancer	0.000164	0.00142	CcSEcCtD
Rosuvastatin—Asthenia—Docetaxel—skin cancer	0.00016	0.00138	CcSEcCtD
Rosuvastatin—Pruritus—Docetaxel—skin cancer	0.000158	0.00136	CcSEcCtD
Rosuvastatin—Diarrhoea—Docetaxel—skin cancer	0.000152	0.00132	CcSEcCtD
Rosuvastatin—Dizziness—Docetaxel—skin cancer	0.000147	0.00127	CcSEcCtD
Rosuvastatin—Rash—Docetaxel—skin cancer	0.000141	0.00121	CcSEcCtD
Rosuvastatin—Dermatitis—Docetaxel—skin cancer	0.00014	0.00121	CcSEcCtD
Rosuvastatin—Headache—Docetaxel—skin cancer	0.00014	0.00121	CcSEcCtD
Rosuvastatin—Nausea—Docetaxel—skin cancer	0.000132	0.00114	CcSEcCtD
